Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein (Q42997747)

12 November 2017

Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

Michael J McGarvey

5

0 references

Stuart J Forbes

object named as

Stuart J Forbes

7

0 references

author name string

Victor V Keasler

1

1 reference

12 November 2017

Herve Lerat

2

1 reference

12 November 2017

Charles R Madden

3

1 reference

12 November 2017

Milton J Finegold

4

1 reference

12 November 2017

Essam M A Mohammed

6

1 reference

12 November 2017

Stanley M Lemon

8

1 reference

12 November 2017

Darryl L Hadsell

9

1 reference

12 November 2017

Shala J Grona

10

1 reference

12 November 2017

F Blaine Hollinger

11

1 reference

12 November 2017

Betty L Slagle

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

20 January 2006

1 reference

12 November 2017

1 reference

12 November 2017

347

1 reference

12 November 2017

2

1 reference

12 November 2017

466-475

1 reference

Neoplasms in Strains of Splenectomized Mice After a Single 7, 12-Dimethylbenz [a]anthracene Treatmentl 2

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

P53 and proliferating cell nuclear antigen (PCNA) expression in non-tumoral liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus. The major etiology of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Epidemiological characteristics and risk factors of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

The hepatitis B virus X gene induces p53-mediated programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Subcellular localisation of NS3 in HCV-infected hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

The susceptibility of various strains of neonatal mice to the carcinogenic effects of 9,10-dimethyl-1,2-benzanthracene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Lower serum hepatitis C virus RNA titers in patients with concurrent chronic hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

The hepatitis B virus HBx protein inhibits caspase 3 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Subcellular localisation of the X protein in HBV infected hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Trans-activation of HLA-DR gene by hepatitis B virus X gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus X protein inhibits nucleotide excision repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Pathogenesis of hepatitis C-associated hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Stimulation of cellular proliferation by hepatitis B virus X protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Modulation of expression of the hepatitis B virus surface antigen gene by the viral X-gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

AGA technical review on nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Epidemiology of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus X protein interacts with a probable cellular DNA repair protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

Hepatitis B virus X protein interferes with cellular DNA repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

inferred from DOI database lookup

7 January 2021

based on heuristic

Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.11.050

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.11.050

1 reference

12 November 2017

1 reference